Blocknomi
Key Takeaways Guggenheim elevated Spyre Therapeutics to its premier biotech selection following encouraging Phase II results for SPY003 in ulcerative colitis treatment The SKYLINE-UC trial demonstrated 20% clinical remission and…
Related articles
-
Palo Alto CEO Says $5 Trillion AI Buildout Needs New Security Stack
BeInCrypto Published 02.09.2026 05:04
-
Apple (AAPL) Closes In on $5 Trillion Valuation as John Ternus Assumes CEO Role
Blocknomi Published 31.08.2026 12:52
-
Telegram’s Gram Wallet Launch Drives GRAM Token Surge with 137% Volume Spike
Blocknomi Published 01.09.2026 07:42
-
Profit Connect owner convicted over $24M AI crypto fraud scheme
CryptoSlate Published 26.08.2026 10:30
-
Hyperliquid Targets Regulated U.S. Perpetual Futures Access
Blocknomi Published 31.08.2026 20:04
-
Foxconn August Revenue Hits $29.2B as AI Server Demand Accelerates
Crypto Daily Published 07.09.2026 12:51
-
DWF Labs Expands Global Regulatory Footprint with BVI Virtual Asset Service Provider Approval
Crypto Daily Published 03.09.2026 12:02
-
Polygon Labs issues urgent client upgrade notice following Austin and Kyoto hardforks
CryptoSlate Published 29.08.2026 09:10